Revenue Breakdown
Composition ()
No data
Revenue Streams
Edesa Biotech Inc (EDSA) generates its revenue primarily from KLH Operation, which accounts for 100.0% of total sales, equivalent to $102.58K. Understanding this concentration is critical for investors evaluating how EDSA navigates market cycles within the Biotechnology & Medical Research industry.
Profitability & Margins
Comparative Benchmarking
In the context of the broader market, EDSA competes directly with industry leaders such as OKUR and CING. With a market capitalization of $156.30M, it holds a significant position in the sector. When comparing efficiency, EDSA's gross margin of N/A stands against OKUR's N/A and CING's N/A. Such benchmarking helps identify whether Edesa Biotech Inc is trading at a premium or discount relative to its financial performance.
